Dudediligence.

Theravance Biopharma Inc

TBPHNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 23 →InsidersNo open-market buys. 2 insiders sold $3.2M, 11 of 15 sales on a 10b5-1 plan.→PeersClosest companies: ZVRA, INCY, CPIX→

From the filings

Figures

Revenue
$104.3Mlast 12 months
Net income
$53.8Mlast 12 months
Operating cash flow
$268.8Mlast 12 months
Cash and equivalents
$219.8Mat the last balance sheet
Shares outstanding
51.9M shareson issue
Every year and quarter →